Serum and Urine Light Chains in AL Amyloidosis

被引：0
|
作者：
Mead, G. P. [1 ]
Stubbs, P. D. [1 ]
Goodman, H. J. B. [2 ]
Hawkins, P. N. [3 ]
机构：
[1] Binding Site Ltd, Birmingham, W Midlands, England
[2] Waikato Hosp, North Isl, New Zealand
[3] Royal Free & Univ Coll Med Sch, London WC1E 6BT, England
来源：
CLINICAL LYMPHOMA & MYELOMA | 2009年 / 9卷
关键词：
D O I：
10.1016/S1557-9190(11)70668-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S106 / S106
页数：1
相关论文
共 50 条
  • [41] Glycosylation of Immunoglobulin Light Chains is Associated with Amyloidosis
    Milani, Paolo
    Barnidge, David
    Murray, David
    Kohlhagen, Mindy
    Sepiashivili, Lusia
    Merlini, Giampaolo
    Dispenzieri, Angela
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E104 - E104
  • [42] FREE LIGHT-CHAINS OF IMMUNOGLOBULINS IN AMYLOIDOSIS
    SOLLING, J
    SOLLING, K
    ACTA MEDICA SCANDINAVICA, 1979, 206 (04): : 283 - 287
  • [43] Glycosylation of immunoglobulin light chains associated with amyloidosis
    Omtvedt, LA
    Bailey, D
    Renouf, DV
    Davies, MJ
    Paramonov, NA
    Haavik, S
    Husby, G
    Sletten, K
    Hounsell, EF
    AMYLOID-INTERNATIONAL JOURNAL OF EXPERIMENTAL AND CLINICAL INVESTIGATION, 2000, 7 (04): : 227 - 244
  • [44] Measurement of free light chains in urine
    Graziani, MS
    Merlini, G
    CLINICAL CHEMISTRY, 2001, 47 (11) : 2069 - 2069
  • [45] MYELOMA WITH A SERUM GAMMAG PARAPROTEIN AND ELIMINATION IN URINE OF A FRAGMENT OF GAMMAG DEPRIVED OF LIGHT CHAINS
    FINE, JM
    ZAKIN, MM
    FAURE, A
    BOFFA, GA
    REVUE FRANCAISE D ETUDES CLINIQUES ET BIOLOGIQUES, 1968, 13 (02): : 175 - &
  • [46] Can serum free light chains replace urine electrophoresis in the detection of monoclonal gammopathies?
    Beetham, Robert
    Wassell, Julie
    Wallagel, Michael J.
    Whiteway, Alastair J.
    James, Jacky A.
    ANNALS OF CLINICAL BIOCHEMISTRY, 2007, 44 : 516 - 522
  • [47] HIGH EARLY MORTALITY AND POOR OUTCOMES FOR PATIENTS WITH AL AMYLOIDOSIS PRESENTING WITH HIGH SERUM FREE LIGHT CHAINS - A NEW RISK STRATIFICATION MODEL
    Wechalekar, A. D.
    Wassef, N.
    Lachmann, H.
    Sattianayagam, P.
    Gibbs, S. D. J.
    Gillmore, J.
    Hawkins, P. N.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 222 - 222
  • [48] In cardiac AL amyloidosis reduction of circulating amyloidogenic light-chains improves myocardial function
    Perlini, S.
    Palladini, G.
    Obici, L.
    Vezzoli, M.
    Clari, F.
    Lavatelli, F.
    Caccialanza, R.
    Merlini, G.
    EUROPEAN HEART JOURNAL, 2005, 26 : 675 - 675
  • [49] Long-term Follow-up of Plasma Cells in Bone Marrow and Serum Free Light Chains in Primary Systemic AL Amyloidosis
    Yoshida, Takuhiro
    Matsuda, Masayuki
    Katoh, Nagaaki
    Tazawa, Ko-ichi
    Shimojima, Yasuhiro
    Gono, Takahisa
    Ishii, Wataru
    Nakazawa, Yozo
    Sakashita, Kazuo
    Koike, Kenichi
    Yamada, Toshiyuki
    Ikeda, Shu-ichi
    INTERNAL MEDICINE, 2008, 47 (20) : 1783 - 1790
  • [50] Correlation of changes in nephelometric quantification of serum monoclonal free light chains following chemotherapy and outcome in 137 patients with systemic AL amyloidosis.
    Lachmann, HJ
    Gallimore, R
    Gillmore, JD
    Smith, L
    Bradwell, AR
    Bradwell, AR
    Hawkins, PN
    CLINICAL CHEMISTRY, 2002, 48 (06) : A165 - A165
12345